produce positive reactions to all four reagents, in many cases owing to recognition of common mycobacterial (group i) antigens.7 Category 2 are nonresponders to all reagents, and category 3 respond to one or more reagents through recognition of their species specific (group iv) antigens.
To provide data generated simultaneously in individuals suffering from a known mycobacterial disease we studied a group of patients with tuberculosis and a healthy control group to tuberculin, but increased responsiveness to the other three reagents; significantly so in the case of scrofulin (p<0001). The only other haplotype found to influence skin test results was DR7, possession of which was associated with decreased responsiveness to tuberculin in rheumatoid patients, but had no effect among patients with tuberculosis or healthy controls (Table 3) .
When the DR types were segregated according to responder category it was found that there was a significant association between DR7 haplotype and skin test non-responsiveness among patients with arthritis, which was not seen among patients with tuberculosis or controls.
Discussion
Our results showed that the incidence of HLA-DR4 was raised significantly among the patients with rheumatoid arthritis we studied in comparison with patients with tuberculosis but not in comparison with the control group. This is not surprising as the work associating this haplotype with the disease was carried out in a quite different population. We also showed that responsiveness to mycobacterial skin test reagents is strikingly reduced in patients with arthritis in comparison with a control group (Table  1) and is associated with DR haplotype. The differences found suggest that patients with arthritis are subject to some form of immune regulation of their responses to mycobacteria. The similarity between these patients and the patients with tuberculosis (both DR4 and non-DR4) in their low responses to leprosin A and scrofulin is striking and suggests similar regulatory mechanisms may control the responses to these reagents in both diseases. The almost normal responses to tuberculin and vaccin and the low responses to leprosin A and scrofulin among DR4 rheumatoid patients show that there is specificity in their responsiveness, and that they are not non-specific high responders.
The increased positivity to skin tests seen among patients with rheumatoid arthritis and tuberculosis with the haplotype DR3 suggests that they may retain a degree of responsiveness to common mycobacterial antigen, possibly to the 65 kilodalton protein (R de Vries, personal communication). 
